Log in

OTCMKTS:TMEDTrimedyne Stock Price, Forecast & News

0.00 (0.00 %)
(As of 03/20/2020)
Today's Range
Now: $4.25
50-Day Range
MA: $4.25
52-Week Range
Now: $4.25
Volume110 shs
Average VolumeN/A
Market Capitalization$510,000.00
P/E RatioN/A
Dividend YieldN/A
Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.
Read More
Trimedyne logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
SectorComputer and Technology
Current SymbolOTCMKTS:TMED



Sales & Book Value

Annual Sales$5.57 million



Market Cap$510,000.00
Next Earnings DateN/A
OptionableNot Optionable

Receive TMED News and Ratings via Email

Sign-up to receive the latest news and ratings for TMED and its competitors with MarketBeat's FREE daily newsletter.

Trimedyne (OTCMKTS:TMED) Frequently Asked Questions

How has Trimedyne's stock been impacted by COVID-19 (Coronavirus)?

Trimedyne's stock was trading at $4.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TMED stock has decreased by 1.2% and is now trading at $4.25. View which stocks have been most impacted by Coronavirus.

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) released its earnings results on Tuesday, February, 20th. The technology company reported $0.70 EPS for the quarter. The technology company earned $1.53 million during the quarter. View Trimedyne's earnings history.

Has Trimedyne been receiving favorable news coverage?

News articles about TMED stock have trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trimedyne earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave news headlines about the technology company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutTrimedyne.

Who are some of Trimedyne's key competitors?

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include AFLAC (AFL), Diana Shipping (DSX), Cohen & Steers Clsd-End Optuny Fnd (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), Ring Energy (REI), Ring Energy (REI), Rank Group (RNK) and Safehold (SAFE).

Who are Trimedyne's key executives?

Trimedyne's management team includes the following people:
  • Mr. Glenn D. Yeik, Interim Chairman, CEO & Pres (Age 51)
  • Mr. Brian T. Kenney, VP of Global Sales & Marketing (Age 62)

What is Trimedyne's stock symbol?

Trimedyne trades on the OTCMKTS under the ticker symbol "TMED."

How do I buy shares of Trimedyne?

Shares of TMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Trimedyne's stock price today?

One share of TMED stock can currently be purchased for approximately $4.25.

How big of a company is Trimedyne?

Trimedyne has a market capitalization of $510,000.00 and generates $5.57 million in revenue each year.

What is Trimedyne's official website?

The official website for Trimedyne is www.trimedyne.com.

How can I contact Trimedyne?

Trimedyne's mailing address is 5 HOLLAND BLDG #223, IRVINE CA, 92618. The technology company can be reached via phone at 949-951-3800.

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.